Apimeds Pharmaceuticals announces 1-for-10 reverse stock split effective July 24, 2026

Apimeds Pharmaceuticals US, Inc.

Reverse stock split at 1-for-10 ratio, effective 12:01 a.m. ET on July 24, 2026.
Stock will trade on NYSE American under symbol APUS on split-adjusted basis from July 24.
New CUSIP number for post-split common stock is 03771D201.
Previously expected effective date of March 26, 2026, was delayed; now set for July 24, 2026.
Every ten pre-split shares will combine into one post-split share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.